JP2015205894A5 - - Google Patents

Download PDF

Info

Publication number
JP2015205894A5
JP2015205894A5 JP2015111995A JP2015111995A JP2015205894A5 JP 2015205894 A5 JP2015205894 A5 JP 2015205894A5 JP 2015111995 A JP2015111995 A JP 2015111995A JP 2015111995 A JP2015111995 A JP 2015111995A JP 2015205894 A5 JP2015205894 A5 JP 2015205894A5
Authority
JP
Japan
Prior art keywords
cells
stro
pharmaceutical composition
composition according
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015111995A
Other languages
English (en)
Japanese (ja)
Other versions
JP6499016B2 (ja
JP2015205894A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015205894A publication Critical patent/JP2015205894A/ja
Publication of JP2015205894A5 publication Critical patent/JP2015205894A5/ja
Application granted granted Critical
Publication of JP6499016B2 publication Critical patent/JP6499016B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015111995A 2008-11-20 2015-06-02 膵機能障害の治療または予防方法 Active JP6499016B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19979608P 2008-11-20 2008-11-20
US61/199,796 2008-11-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011536703A Division JP5891034B2 (ja) 2008-11-20 2009-11-19 膵機能障害の治療または予防方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017112578A Division JP2017214384A (ja) 2008-11-20 2017-06-07 膵機能障害の治療または予防方法

Publications (3)

Publication Number Publication Date
JP2015205894A JP2015205894A (ja) 2015-11-19
JP2015205894A5 true JP2015205894A5 (https=) 2019-02-28
JP6499016B2 JP6499016B2 (ja) 2019-04-10

Family

ID=42197754

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2011536703A Active JP5891034B2 (ja) 2008-11-20 2009-11-19 膵機能障害の治療または予防方法
JP2015111995A Active JP6499016B2 (ja) 2008-11-20 2015-06-02 膵機能障害の治療または予防方法
JP2017112578A Withdrawn JP2017214384A (ja) 2008-11-20 2017-06-07 膵機能障害の治療または予防方法
JP2019162845A Active JP7051770B2 (ja) 2008-11-20 2019-09-06 膵機能障害の治療または予防方法
JP2021177234A Withdrawn JP2022031662A (ja) 2008-11-20 2021-10-29 膵機能障害の治療または予防方法
JP2023086994A Active JP7751607B2 (ja) 2008-11-20 2023-05-26 膵機能障害の治療または予防方法
JP2025099335A Pending JP2025148353A (ja) 2008-11-20 2025-06-13 膵機能障害の治療または予防方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011536703A Active JP5891034B2 (ja) 2008-11-20 2009-11-19 膵機能障害の治療または予防方法

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2017112578A Withdrawn JP2017214384A (ja) 2008-11-20 2017-06-07 膵機能障害の治療または予防方法
JP2019162845A Active JP7051770B2 (ja) 2008-11-20 2019-09-06 膵機能障害の治療または予防方法
JP2021177234A Withdrawn JP2022031662A (ja) 2008-11-20 2021-10-29 膵機能障害の治療または予防方法
JP2023086994A Active JP7751607B2 (ja) 2008-11-20 2023-05-26 膵機能障害の治療または予防方法
JP2025099335A Pending JP2025148353A (ja) 2008-11-20 2025-06-13 膵機能障害の治療または予防方法

Country Status (10)

Country Link
US (3) US8894972B2 (https=)
EP (2) EP2350266B1 (https=)
JP (7) JP5891034B2 (https=)
KR (2) KR102011609B1 (https=)
CN (3) CN102307992B (https=)
AU (1) AU2009317874B2 (https=)
CA (1) CA2744228C (https=)
DK (1) DK2350266T3 (https=)
ES (2) ES2550795T3 (https=)
WO (1) WO2010057260A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008006168A1 (en) * 2006-07-12 2008-01-17 Angioblast Systems, Inc. Treatment of excessive neovascularization
ES2550795T3 (es) * 2008-11-20 2015-11-12 Mesoblast, Inc. Método para tratar o prevenir una disfunción pancreática
CN107149679B (zh) 2009-03-05 2021-03-02 哈佛学院董事会 分泌的aP2及其抑制方法
KR101891260B1 (ko) * 2010-07-02 2018-08-24 메소블라스트, 아이엔씨. T-세포 매개된 면역 질환의 치료
CN107638428B (zh) * 2011-05-19 2021-07-23 麦瑟布莱斯特公司 用于治疗肥胖症和/或代谢综合征的方法
AU2012262675B2 (en) * 2011-06-03 2016-05-19 Mesoblast, Inc Methods of treating or preventing neurological diseases
CA2839341C (en) * 2011-07-04 2020-12-15 Mesoblast, Inc. Methods of treating or preventing rheumatic disease
CN104508124B (zh) 2011-07-06 2017-11-17 细胞治疗有限公司 中胚层谱系祖细胞
CN104098682B (zh) * 2013-04-03 2018-01-02 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN105358163B (zh) * 2012-12-12 2020-09-11 麦瑟布莱斯特公司 内皮功能障碍和炎症的疾病的治疗
US20140314872A1 (en) * 2013-04-22 2014-10-23 Hans Klingemann Methods of Use of Culture Supernatant Obtained from Mesenchymal Stem Cells from Dogs and Cats for Treatment of Organ Dysfunction
CN104714021B (zh) * 2013-12-12 2016-05-25 张曼 尿液凝血酶原蛋白在2型糖尿病合并冠心病中的应用
TW201702271A (zh) 2015-04-30 2017-01-16 哈佛大學校長及研究員協會 治療代謝病症之抗－ａｐ２抗體及抗原結合劑
BR112018076703A2 (pt) * 2016-06-27 2019-04-02 President And Fellows Of Harvard College compostos úteis para tratar distúrbios metabólicos
WO2018227200A1 (en) 2017-06-09 2018-12-13 President And Fellows Of Harvard College Method to identify compounds useful to treat dysregulated lipogenesis, diabetes, and related disorders
CN110959579A (zh) * 2019-11-14 2020-04-07 顾隽 患者来源的淋巴瘤免疫缺陷小鼠移植瘤模型的构建方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
AU8200191A (en) 1990-07-09 1992-02-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The High efficiency packaging of mutant adeno-associated virus using amber suppressions
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
DE69233013T2 (de) 1991-08-20 2004-03-04 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
DE19939781C2 (de) 1999-08-21 2003-06-18 Schott Glas Skulltiegel für das Erschmelzen oder das Läutern von anorganischen Substanzen, insbesondere von Gläsern und Glaskeramiken
WO2004016747A2 (en) * 2002-08-14 2004-02-26 University Of Florida Bone marrow cell differentiation
US9631176B2 (en) * 2003-11-04 2017-04-25 Biomaster, Inc. Method for preparing stem cells from fat tissue
CN101506355B (zh) * 2004-09-24 2012-06-27 成血管细胞系统公司 多能扩增间充质前体细胞子代（memp）及其应用
CN101248171B (zh) * 2005-04-12 2015-11-25 迈索布拉斯特股份有限公司 通过组织非特异性碱性磷酸酶分离成人多潜能细胞
GB0514785D0 (en) * 2005-07-19 2005-08-24 Innovia Films Ltd Sealed ream wrap package and films suitable for forming such packages
AU2007243221A1 (en) * 2006-04-28 2007-11-08 Tulane University Health Sciences Center Methods for treating diabetes
AU2008210988B2 (en) * 2007-02-01 2012-09-06 Allocure, Inc. Potentiation of stem cell homing and treatment of organ dysfunction or organ failure
ES2550795T3 (es) 2008-11-20 2015-11-12 Mesoblast, Inc. Método para tratar o prevenir una disfunción pancreática
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit

Similar Documents

Publication Publication Date Title
JP2015205894A5 (https=)
Xie et al. Functional dental pulp regeneration: basic research and clinical translation
Molnar et al. Mesenchymal stem cell mechanisms of action and clinical effects in osteoarthritis: a narrative review
Köhnke et al. Temporomandibular joint osteoarthritis: regenerative treatment by a stem cell containing advanced therapy medicinal product (ATMP)—An in vivo animal trial
Jensen et al. Functionalization of polycaprolactone scaffolds with hyaluronic acid and β-TCP facilitates migration and osteogenic differentiation of human dental pulp stem cells in vitro
Hernández-Monjaraz et al. Mesenchymal stem cells of dental origin for inducing tissue regeneration in periodontitis: a mini-review
de Bakker et al. Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man
Smojver et al. Mesenchymal stem cells based treatment in dental medicine: a narrative review
Li et al. Improved fat graft survival by different volume fractions of platelet-rich plasma and adipose-derived stem cells
Baru et al. Angiogenesis in regenerative dentistry: are we far enough for therapy?
Woloszyk et al. Influence of the mechanical environment on the engineering of mineralised tissues using human dental pulp stem cells and silk fibroin scaffolds
MA34057B1 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
Xu et al. Roles of cartilage-resident stem/progenitor cells in cartilage physiology, development, repair and osteoarthritis
Müller et al. Amorphous, smart, and bioinspired polyphosphate nano/microparticles: a biomaterial for regeneration and repair of osteo-articular impairments in-situ
Mohd Nor et al. From teeth to therapy: a review of therapeutic potential within the secretome of stem cells from human exfoliated deciduous teeth
Lee et al. Stem and progenitor cell microenvironment for bone regeneration and repair
Song et al. Mesenchymal stromal cells in osteoarthritis: evidence for structural benefit and cartilage repair
Cullier et al. Functionalized nanogels with endothelin-1 and bradykinin receptor antagonist peptides decrease inflammatory and cartilage degradation markers of osteoarthritis in a horse organoid model of cartilage
RU2014146291A (ru) Способ использования сложных эфиров азелаиновой кислоты для модуляции передачи сигналов, медиируемых биологическими молекулами
Liu et al. The involving roles of intrahepatic and extrahepatic stem/progenitor cells (SPCs) to liver regeneration
EA201690005A1 (ru) Состав с модифицированной кинетикой высвобождения
Ning et al. Microfiber-reinforced composite hydrogels loaded with rat adipose-derived stem cells and BMP-2 for the treatment of medication-related osteonecrosis of the jaw in a rat model
Di Vito et al. A review of novel strategies for human periodontal ligament stem cell ex vivo expansion: are they an evidence-based promise for regenerative periodontal therapy?
EA201791138A1 (ru) Фармацевтическая композиция, ее приготовление и применения